ZONISAMIDE AS A NEUROPROTECTIVE AGENT IN AN ADULT GERBIL MODEL OF GLOBAL FOREBRAIN ISCHEMIA - A HISTOLOGICAL, IN-VIVO MICRODIALYSIS AND BEHAVIORAL-STUDY
Aj. Owen et al., ZONISAMIDE AS A NEUROPROTECTIVE AGENT IN AN ADULT GERBIL MODEL OF GLOBAL FOREBRAIN ISCHEMIA - A HISTOLOGICAL, IN-VIVO MICRODIALYSIS AND BEHAVIORAL-STUDY, Brain research, 770(1-2), 1997, pp. 115-122
Brief periods of global cerebral ischemia are known to produce charact
eristic patterns of neuronal injury both in human studies and in exper
imental animal models. Ischemic damage to vulnerable areas such as the
CA1 sector of the hippocampus is thought to result from excitotoxic a
mino acid neurotransmission. The objective of this study was to determ
ine the ability of a novel sodium channel blocking compound, zonisamid
e, to reduce neuronal damage by preventing the ischemia-associated acc
umulation of extracellular glutamate. Using gerbil model, animals were
subjected to 5 min ischemic insults. Both pre- and post-ischemic drug
administration (zonisamide 150 mg/kg) were studied. Histological brai
n sections were prepared using a silver stain at 7 and 28 days post is
chemia. The animals sacrificed at 28 days also underwent behavioral te
sting using a modified Morris water maze. In vivo microdialysis was pe
rformed on a separate group of animals in order to determine the patte
rns of ischemia-induced glutamate accumulation in the CA1 sector of th
e hippocampus. Pyramidal cell damage scores in the CA1 region of the h
ippocampus were significantly reduced in animals pre-treated with zoni
samide compared to saline-treated controls, both at 7 days (drug pre-t
reated: 0.812 +/- 0.28, n = 8; controls: 1.625 +/- 0.24, n = 8; P < 0
.05) and 28 (drug pre-treated: 0.833 +/- 0.22, n = 12; controls: 1.955
+/- 0.26, n = 11; *P < 0.01) days post ischemia. However, animals re
ceiving zonisamide post-treatment did not display significant differen
ces from controls. Behavioral studies also showed significant preserva
tion of function in drug-treated animals. Microdialysis studies confir
med a reduction in glutamate release in drug-treated animals compared
to saline-treated controls. Our data suggest that zonisamide is effect
ive in reducing neuronal damage by a mechanism involving decreased isc
hemia-induced extracellular glutamate accumulation and interruption of
excitotoxic pathways. (C) 1997 Elsevier Science B.V.